An unsuccessful IVF cycle can be devastating—especially when you have spent months preparing physically, emotionally, and financially for the possibility of pregnancy.
But the phrase “IVF failure” can mean several very different things.
A cycle might not result in:
Each outcome raises different questions.
One unsuccessful cycle does not necessarily mean there is something fundamentally wrong, and it does not automatically mean you need a surrogate, egg donor, or another major change in treatment.
The most useful next step is usually to review exactly where the cycle stopped, what information your fertility specialist learned, and whether there is evidence that changing the treatment plan could improve the next attempt.
Here’s what intended parents should understand before deciding what comes next.
IVF is not one event.
It is a series of biological and medical stages:
A problem at Step 2 is very different from a problem at Step 9.
For example:
If few eggs are retrieved, the conversation may focus on ovarian reserve, age, or the stimulation protocol.
If eggs are retrieved but few embryos develop, egg quality, sperm factors, fertilization, or embryo development may become more relevant.
If good-quality embryos repeatedly fail to implant, the physician may look more closely at embryo genetics, the uterine cavity, transfer technique, endometrial preparation, or other factors.
If pregnancy begins but repeatedly ends in miscarriage, that is different again.
This is why the first question after an unsuccessful cycle should not simply be:
“Why did IVF fail?”
It should be:
“At what stage did our cycle stop, and what does that tell us?”
This distinction is very important.
A single embryo that fails to implant does not mean someone has recurrent implantation failure.
Even transferring a chromosomally normal embryo cannot guarantee pregnancy.
The American Society for Reproductive Medicine updated its guidance on recurrent implantation failure in 2026 and emphasizes that the diagnosis should reflect multiple unsuccessful transfers relative to the expected cumulative probability of implantation.
In other words, physicians should not label someone with a complicated implantation disorder simply because one transfer did not work.
That can lead anxious patients into unnecessary testing and expensive treatments that have not been shown to improve live-birth rates.
Sometimes the first difficulty occurs before eggs are ever retrieved.
The ovaries may not respond to medication as expected.
Possible factors can include:
A fertility specialist may review markers such as ovarian-reserve testing, previous cycle response, medication dosing, and ultrasound findings before recommending another retrieval.
Occasionally, a cycle is cancelled because too few follicles develop or because the response creates a medical concern.
A cancelled retrieval can feel like a failure.
Medically, however, cancelling a cycle that is unlikely to produce an appropriate result—or could put the patient at unnecessary risk—may be the safest decision.
Not every egg retrieved during IVF is mature enough to be fertilized.
The number of follicles seen on ultrasound, eggs retrieved, and mature eggs available for fertilization will not always be identical.
If egg maturity is lower than expected, your reproductive endocrinologist may review:
One unusual cycle does not always predict what will happen in another.
But repeated patterns can provide useful information.
Fertilization requires both a mature egg and functional sperm.
If fertilization is unexpectedly low, your fertility clinic and embryology laboratory may consider factors involving:
In some circumstances, intracytoplasmic sperm injection—or ICSI—may be considered, in which a single sperm is injected directly into a mature egg.
Whether ICSI is appropriate depends on the individual case.
It is not automatically necessary for every IVF cycle.
Fertilization is only the beginning.
Embryos must continue dividing and developing over several days.
Some fertilized eggs naturally stop developing before reaching the blastocyst stage.
This attrition can be emotionally difficult because intended parents may begin with a promising number of retrieved eggs and then watch that number decrease at each stage.
For example:
Retrieved eggs
→ Mature eggs
→ Fertilized eggs
→ Developing embryos
→ Blastocysts
→ Genetically suitable embryos, if testing is used
This reduction is a normal part of IVF biology.
But unusually poor embryo development may prompt your fertility clinic to review egg factors, sperm factors, age, laboratory findings, and the specifics of the cycle.
One of the strongest predictors of embryo chromosomal abnormalities is the age of the person who provided the egg.
As egg age increases, the proportion of embryos with chromosomal abnormalities generally increases.
Chromosomally abnormal embryos often:
This is why egg age can remain highly relevant even when an intended mother is otherwise healthy.
It also helps explain why donor eggs from younger screened donors can sometimes be considered after repeated cycles involving poor egg or embryo quality.
If egg donation becomes part of the conversation, read our guide to Using Donor Eggs to Become a Parent and our Egg Donation Process for Intended Parents.
This can be especially frustrating because everything may appear to have gone well.
You had an embryo.
The transfer occurred.
The uterine lining looked appropriate.
And then the pregnancy test was negative.
Sometimes there is no single identifiable explanation.
Embryo implantation is biologically complex.
Possible factors can include:
But it is important not to assume that every failed transfer means the uterus has an implantation problem.
Embryo factors remain extremely important.
A euploid embryo is one that has been tested and found to have the expected number of chromosomes through PGT-A.
Euploid embryos generally have a better chance of implantation than chromosomally abnormal embryos.
But PGT-A does not guarantee implantation, pregnancy, or birth.
A euploid embryo can still fail to implant.
That does not necessarily mean the carrier’s body rejected it or that something was done wrong.
ASRM notes that even single euploid embryo transfers do not have 100% success rates.
Repeated unsuccessful euploid transfers may eventually justify a more detailed evaluation.
One unsuccessful euploid transfer generally does not justify jumping immediately to every available implantation test or treatment.
Recurrent implantation failure—or RIF—generally refers to repeated failure of embryos to implant after embryo transfer.
Historically, different clinics and researchers have used different definitions.
ASRM’s 2026 guidance specifically recognizes that there has not been one universally accepted definition.
Its current approach considers the expected cumulative chance of implantation based on factors such as:
Depending on those circumstances, recurrent implantation failure may not be considered until several appropriate embryo transfers have failed.
The practical lesson for patients is simpler:
Do not diagnose yourself with recurrent implantation failure after one unsuccessful transfer.
Your fertility specialist should interpret your results in the context of your embryos and complete reproductive history.
A careful review may include:
Was it tested?
Was it euploid?
What stage and grade was it?
How did it survive thawing?
Were there other embryos from the same cycle?
Was the transfer technically straightforward?
Was catheter placement appropriate?
Was there anything unusual during the procedure?
Were estrogen and progesterone levels and timing appropriate for the type of transfer cycle?
Has the uterus been appropriately evaluated for:
Has implantation happened before?
Have there been miscarriages?
Were previous pregnancies uncomplicated?
Depending on the individual history, conditions such as endometriosis or adenomyosis may be considered.
The purpose is not to order every test available.
It is to identify testing that is actually relevant to your history.
Uterine-cavity evaluation is an established part of fertility treatment.
After repeated failed transfers, ASRM says repeat evaluation may sometimes be reasonable, particularly if there is reason to suspect that something may have changed.
Methods may include:
Your physician determines which evaluation is appropriate.
Repeated invasive testing should not automatically occur after every unsuccessful transfer.
One of the hardest parts of repeated IVF failure is that intended parents become understandably willing to try almost anything.
That makes this an area where unsupported treatments can become especially appealing.
You may hear about:
Some of these approaches may be appropriate in specific medical circumstances.
Others remain investigational or have not been shown to improve live-birth rates when used routinely for recurrent implantation failure.
ASRM’s current guidance specifically finds insufficient evidence to recommend routine use of endometrial receptivity panels such as ERA for recurrent implantation failure.
It also does not recommend routine IVIG, G-CSF, endometrial scratching, BCL-6 testing, or anticoagulation without an appropriate medical indication for this purpose.
That does not mean your physician will never recommend additional testing.
It means:
Ask what evidence supports the test in someone with your specific history.
Not necessarily.
PGT-A can provide information about embryo chromosome number and may be useful in selected situations.
But it is not a treatment for every cause of implantation failure.
ASRM’s 2026 guidance notes that PGT-A may be considered in patients with recurrent implantation failure involving untested embryos as part of shared decision-making.
However, current evidence has not shown that PGT-A itself increases live-birth rates in patients with recurrent implantation failure.
That distinction matters.
Testing can provide information.
Information is not the same thing as a guaranteed treatment.
Yes, depending on where the IVF process is breaking down.
Sperm contributes half of the embryo’s genetic material.
A fertility specialist may review:
In some circumstances, additional male-factor evaluation may be appropriate.
But more testing is not always better.
For example, ASRM’s current recurrent-implantation-failure guidance does not recommend routine sperm DNA-fragmentation testing specifically for recurrent implantation failure because evidence that testing and treatment improve live-birth outcomes remains insufficient.
Again, the question should be:
Does this test make sense for our particular IVF history?
People undergoing IVF frequently blame themselves after an unsuccessful cycle.
Maybe I worked too much.
Maybe I was too anxious.
Maybe I didn’t rest enough.
Maybe we traveled.
Maybe I was too stressed.
Fertility treatment is emotionally stressful.
But intended parents should be very cautious about turning that emotional reality into self-blame.
A failed IVF cycle is usually the result of complex reproductive biology—not a punishment for being worried about whether IVF would work.
You deserve emotional support because IVF is difficult.
You do not need emotional support because your anxiety “caused” your cycle to fail.
Usually, there is no basis for making that assumption.
And the same principle applies when a gestational surrogate is carrying the embryo.
A negative pregnancy test after embryo transfer does not automatically mean:
If a physician identifies a specific medical issue, that can be addressed.
Otherwise, assigning blame is both medically inappropriate and emotionally damaging.
That is different from failed implantation.
Once there has been a positive pregnancy, biochemical pregnancy, clinical pregnancy, or miscarriage, the medical question changes.
ASRM now defines recurrent pregnancy loss as two or more spontaneous pregnancy losses.
Evaluation of recurrent pregnancy loss can involve different considerations from evaluation of recurrent implantation failure.
That distinction matters because the tests and treatments are not necessarily interchangeable.
Your reproductive endocrinologist should clarify whether your history primarily involves:
failure to implant
or
pregnancy loss after implantation.
There is no universal answer.
Your physician may recommend another cycle relatively soon if:
In other circumstances, it may make sense to pause.
You may need:
The medically fastest next step is not always the personally right next step.
Egg donation may become relevant when repeated cycles suggest that obtaining viable embryos from someone’s own eggs is increasingly difficult.
That can occur because of:
A donor egg changes the egg source.
It does not change who carries the pregnancy unless you also use a gestational surrogate.
That distinction is important when deciding which part of the IVF process needs to change.
Review our Egg Donation Guide for Intended Parents if this option has entered the conversation.
A gestational surrogate changes who carries the pregnancy.
She does not change the embryo itself.
Surrogacy may be worth discussing when an intended parent:
ASRM’s current recurrent-implantation-failure guidance specifically notes that using a gestational carrier may be considered after several failed embryo transfers.
But this requires careful interpretation.
This deserves its own section because intended parents are sometimes led to believe that moving embryos into a “better uterus” will automatically solve repeated IVF failure.
It won’t necessarily.
If embryos are repeatedly chromosomally abnormal because of egg age, transferring those embryos to a surrogate does not make them chromosomally normal.
If there is a significant sperm-related issue affecting embryo development, changing the uterus does not correct the sperm.
If embryos repeatedly stop developing before transfer, the gestational carrier has not even entered the equation yet.
Surrogacy is most logical when the medical concern involves pregnancy or implantation in the intended mother’s uterus, or when pregnancy itself is medically contraindicated.
Your reproductive endocrinologist should help determine whether the evidence points more strongly toward:
That distinction can prevent families from spending significant money on a solution that does not address the actual problem.
Yes.
Some intended parents face challenges with both creating embryos and carrying a pregnancy.
For example, someone may have age-related egg-quality issues and a medical condition that makes pregnancy unsafe.
In that case, donor eggs may help address the embryo side of the equation while a gestational surrogate addresses the pregnancy side.
Gay male couples and single fathers also generally use both an egg donor and gestational surrogate as part of their family-building process.
These are two distinct medical and logistical roles.
Simple Surrogacy coordinates both services for families who need them.
Then the conversation may be different.
If you have good-quality or euploid frozen embryos and repeated transfer attempts have failed, your physician may focus more heavily on:
If several appropriate embryo transfers have failed despite careful evaluation, discussing a gestational carrier may eventually become reasonable.
Our Surrogacy Process for Intended Parents explains what happens if you decide to explore that path.
There is no universal number of cycles at which someone “should” stop.
For some intended parents, another cycle is medically and emotionally reasonable.
For others, continuing treatment may offer very little realistic benefit.
Consider:
What does your physician believe another cycle could realistically accomplish?
Will the next attempt use a meaningfully different strategy, or are you repeating essentially the same treatment?
How is treatment affecting the person undergoing retrievals or transfers?
What is repeated treatment doing to you individually and as a couple?
Can you continue treatment without creating financial harm that will affect your eventual family?
Would donor eggs, donor sperm, donor embryos, gestational surrogacy, adoption, or another pathway better address the obstacle you are facing?
Stopping one treatment is not necessarily giving up on parenthood.
Sometimes it is choosing a different route.
Consider asking:
At what stage did our cycle differ from what you expected?
What did you learn from this cycle that you did not know before?
Do you think this result was statistical chance or evidence of a recurring problem?
Was ovarian response appropriate?
How many eggs were mature?
Was fertilization what you expected?
How did our embryos develop?
Do you think egg quality is a significant issue?
Do you see evidence of a sperm-related issue?
Does the uterine cavity need additional evaluation?
Was the embryo transfer technically straightforward?
Would you recommend changing the protocol? Why?
Which additional tests have evidence that they could change our management?
Are there tests or treatments you do not recommend?
At what point would you consider donor eggs?
At what point would you consider a gestational surrogate?
What do you think our realistic chance is if we repeat treatment?
A good consultation should help you understand not just what your doctor recommends—but why.
A second opinion does not mean you distrust your fertility doctor.
After several unsuccessful cycles, another reproductive endocrinologist may interpret the history differently or confirm that your current approach is reasonable.
Bring:
The more information the second physician can review, the more useful the consultation will be.
A negative pregnancy test after IVF is not “just another period.”
It may represent:
months of injections,
medical procedures,
thousands of dollars,
embryos you watched develop,
plans you quietly began making,
and another delay in becoming a parent.
You may feel:
Those reactions do not mean you are handling infertility badly.
They mean the experience matters to you.
A therapist or counselor experienced in infertility and third-party reproduction can help, especially when you are deciding whether to continue IVF or move toward donor conception or surrogacy.
Unsuccessful cycles occur even in good-prognosis patients. One failed cycle does not automatically indicate recurrent implantation failure or mean IVF cannot work.
Sometimes there is no identifiable reason. Embryo genetics, developmental competence, uterine factors, hormonal preparation, transfer technique, and chance can all play roles.
Yes. A euploid embryo has a better chance of implantation than an aneuploid embryo but does not guarantee pregnancy.
There is no simple universal number that applies to everyone. Current ASRM guidance considers embryo quality, testing status, age, and cumulative expected implantation probability. Multiple appropriate transfers are generally required before the term is used.
Not routinely. Current ASRM guidance finds insufficient evidence to recommend routine endometrial receptivity testing for recurrent implantation failure.
Not simply because an embryo transfer failed. Several commonly marketed immunologic treatments lack evidence that they improve live-birth rates in recurrent implantation failure. Discuss any proposed treatment with your reproductive endocrinologist.
No. PGT-A can provide chromosome information about embryos, but it cannot guarantee implantation or birth and has not been shown to increase live-birth rates specifically in recurrent implantation failure.
No. First determine whether the suspected issue involves the embryo, uterus, pregnancy, or another factor.
A gestational surrogate may be appropriate when the concern involves the intended parent’s ability to safely carry or sustain a pregnancy or after certain cases of repeated implantation failure. She cannot correct poor embryo quality or chromosomal abnormalities.
Donor eggs may be more relevant when repeated treatment indicates that egg quality, ovarian reserve, age-related aneuploidy, or certain genetic issues are the primary obstacle.
Yes. Some intended parents need assistance both creating viable embryos and carrying the pregnancy.
Not necessarily. But after repeated unsuccessful treatment, reviewing your cycle in detail or seeking a second opinion can be reasonable.
Usually there is no basis for that conclusion. IVF depends on complex biology, and many aspects are outside anyone’s control.
IVF failure can feel final in the moment.
It usually isn’t.
But moving forward should involve more than automatically repeating the same cycle—or immediately jumping to the most expensive alternative.
First understand what happened.
Was the problem getting eggs?
Creating embryos?
Embryo chromosome status?
Implantation?
Pregnancy loss?
Carrying the pregnancy safely?
Those answers help determine which path makes sense next.
For one family, that may be another IVF cycle.
For another, it may be donor eggs.
For another, a gestational surrogate.
For some families, it may eventually be both.
At Simple Surrogacy, we are not the fertility clinic and should not diagnose why your IVF treatment failed. That belongs with your reproductive endocrinologist.
Our role begins when third-party reproduction becomes part of the solution.
If your physician has recommended donor eggs, you can learn more about our Egg Donation Program and Egg Donation Process.
If carrying the pregnancy has become the concern, review our Surrogacy Process for Intended Parents or contact Simple Surrogacy to discuss what a gestational-carrier journey involves.
The goal is not simply to keep trying IVF.
The goal is to understand what is standing between you and parenthood—and choose the path most likely to address it.
Go backSurrogacy 101: Becoming an Intended Parent Through Surrogacy Becoming an intended parent through surrogacy can feel exciting, hopeful—and, at first, a little overwhelming. Most people begin the process with far more questions than answers. Do you need embryos before contacting…
Lern more →Why Surrogates Should Think Twice Before Choosing an Agency That Also Represents the Intended Parents Choosing a surrogacy agency is one of the most important decisions a gestational carrier will make during her journey. Your agency is often the central…
Lern more →Surrogacy Pregnancy and Delivery: What Intended Parents and Surrogates Should Expect Quick Summary Once an embryo transfer results in an established pregnancy, a surrogacy journey enters a very different stage. The fertility clinic eventually releases the gestational surrogate to her…
Lern more →
